A study on cognitive dysfunction improvement of aripiprazole for Japanese schizophrenia patients.
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2014
Price : $35 *
At a glance
- Drugs Aripiprazole (Primary) ; Risperidone
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 28 Oct 2014 Status changed from not yet recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 02 Jul 2014 New trial record